Skip to content
OpenCapital
Get started

Dare Bioscience, Inc. DARE Q2 2025 earnings

Reported August 14, 2025 · After market close

Revenue-$21.2KMiss by $168.4K
EPS-$0.45Beat by $0.10
Revenue estimate$147.3K
EPS estimate-$0.55

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$1.7K
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$152.5KBeat by $125.5KQ4 2025$1.0MBeat by $272.2KQ3 2025$2.3KMiss by $762.7K
Q2 2025-$21.2KMiss by $168.4K
Q1 2025$25.4KMiss by $574.6KQ4 2024-$63.6KMiss by $1.1M

Diluted EPS

Q1 2026-$0.20Beat by $0.13Q4 2025-$0.02Beat by $0.22Q3 2025-$0.28Beat by $0.05
Q2 2025-$0.45Beat by $0.10
Q1 2025-$0.50Beat by $0.13Q4 2024-$0.64Beat by $0.02

Ask the moment Dare Bioscience, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dare Bioscience, Inc. report Q2 2025 earnings?
Dare Bioscience, Inc. (DARE) reported Q2 2025 earnings on August 14, 2025 after market close.
What were Dare Bioscience, Inc.'s Q2 2025 revenue and EPS?
Dare Bioscience, Inc. reported revenue of -$21.2K and eps of $-0.45 for Q2 2025.
Did Dare Bioscience, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $147.3K by $168.4K. EPS beat the consensus estimate of $-0.55 by $0.10.
How did Dare Bioscience, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 194.4% from $22.4K a year earlier.
Where can I find Dare Bioscience, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001401914-25-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.